Gilead Says European CHMP Adopts Positive Opinion For Its Odefsey For Treating HIV
April 29, 2016 at 09:42 AM EDT
Gilead Sciences, Inc. (NASDAQ: GILD) disclosed the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of ...